Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating expenses:    
Research and development $ 470,976 $ 544,302
General and administrative 1,403,465 1,159,289
Total operating expenses 1,874,441 1,703,591
Operating loss (1,874,441) (1,703,591)
Other income, net 59 37
Loss before income taxes (1,874,382) (1,703,554)
Income taxes
Net loss $ (1,874,382) $ (1,703,554)
Loss per common share - basic and diluted (in dollars per share) $ (0.71) $ (5.40)
Weighted average shares outstanding, basic and diluted (in shares) 2,651,952 315,576